A NOVEL FILLER
OPTIMIZING CLINICAL PERFORMANCE & PATIENT OUTCOMES
PROVEN QUALITY
AiLEENE is manufactured in CGBIO facilities certified ISO13485, AATB & FDA HCT/P. In addition to CE certification, CG Bio announced on July 25th 2023, that its hyaluronic acid (HA) filler, AiLEENE has obtained product approval from the Australian Federal Medical Products Administration (TGA). This achievement expands its presence to approximately 31 countries globally.
NATURAL & VISIBLE RESULTS
AiLEENE offers natural and visible results due to its higher elasticity and viscosity compared to other dermal fillers. What sets AiLEENE apart is its unique combination of physical properties: cohesion, necessary for smooth injection, and lifting capacity, required for volume restoration.
SMOOTH INJECTION
AiLEENE injection provides a softer and more stable extrusion force compared to other fillers.
NO SWELLING
AiLEENE has been studied for its level of HA hydration, which minimizes swelling and edema after treatment.
WELL TOLERATED
AilLEENE has a low crosslinking ratio (degree of modification), indicating a low level of transformation from natural hyaluronic acid. This makes it a well-tolerated filler, with the crosslinking ratio being approximately 2%.
EASILY REMOVED
The HA filler is completely degraded within 2 hours of treatment with 300 U/ml hyaluronidase.
NATURAL & VISIBLE RESULTS
Chin & Jawline – by Dr. Nakhle Ayoub
Before
After
CGBio specializes in bio regenerative medicine and offers a high-quality product portfolio, which includes aesthetic products, allografts, DBM, synthetic bone grafts, spinal implants, NPWT, growth factors and advanced wound dressings. The company heavily invests in research and development and has a global presence. On August 14, 2023, CGBio announced the acquisition of FDA 510(k) clearance for its Advanced LumFix Spinal Fixation System, also known as the ‘Advanced LumFix‘
CGBIO, unveiling next-generation cage ‘Excender’ and 3D implant manufacturing system ‘PSI Platform’ in the US